Keyphrases
Placebo
100%
Chronic Heart Failure
100%
Valsartan
100%
Point-of-care
100%
Healthcare Data
100%
Clinical Trial Results
100%
Individual Symptoms
50%
Clinical Trials
25%
Risk Stratification
25%
NYHA Class
25%
Heart Failure Hospitalization
25%
Multivariate Analysis
25%
Prognostic Value
25%
Mortality Rate
25%
Mortality Prediction
25%
Hospitalization
25%
Left Ventricular Dysfunction
25%
Hazard Ratio
25%
Symptom Score
25%
Patient Benefit
25%
Therapeutic Value
25%
Analysis of Covariance
25%
Treatment Difference
25%
Logistical Regression
25%
Overall Scores
25%
Symptomatic Patients
25%
Severe Symptoms
25%
Trial Results
25%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial Results
100%
Placebo
100%
Physical Disease by Body Function
100%
Congestive Heart Failure
100%
Valsartan
100%
Clinical Trial
25%
Mortality Rate
25%
Heart Left Ventricle Failure
25%